PDB-4xaw: Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: Crystals cryoprotected with phosphatidic acid (08:0 PA) Method: X-RAY DIFFRACTION / Resolution: 1.47 Å
PDB-4xbe: Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: crystals cryoprotected with sphingomyelin (02:0 SM (d18:1/2:0)). Method: X-RAY DIFFRACTION / Resolution: 1.756 Å
PDB-4xbg: Crystal structure of human 4E10 Fab in complex with phosphatidic acid (06:0 PA): 2.73 A resolution Method: X-RAY DIFFRACTION / Resolution: 2.73 Å
PDB-4xbp: Crystal structure of human 4E10 Fab crystalized in the presence of Phosphatidylethanolamine (06:0 PE) Method: X-RAY DIFFRACTION / Resolution: 2.94 Å
PDB-4xc1: Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 GP41: crystals cryoprotected with sn-Glycerol 3-phosphate Method: X-RAY DIFFRACTION / Resolution: 1.63 Å
PDB-4xc3: Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41; crystals cryoprotected with rac-glycerol 1-phosphate Method: X-RAY DIFFRACTION / Resolution: 1.63 Å
PDB-4xcc: Crystal structure of human 4E10 Fab crystalized in the presence of Phosphatidylcholine (06:0 PC); I422 space group Method: X-RAY DIFFRACTION / Resolution: 2.81 Å
PDB-4xce: Crystal structure of human 4E10 Fab crystalized in the presence of Phosphatidylcholine (06:0 PC); C2 space group Method: X-RAY DIFFRACTION / Resolution: 2.93 Å
PDB-4xcf: Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41; crystals cryoprotected with phosphatidylcholine (03:0 PC) Method: X-RAY DIFFRACTION / Resolution: 1.43 Å
PDB-4xcn: Crystal structure of human 4E10 Fab in complex with phosphatidic acid (06:0 PA); 2.9 A resolution Method: X-RAY DIFFRACTION / Resolution: 2.9 Å
PDB-4xcy: Crystal structure of human 4E10 Fab in complex with phosphatidylglycerol (06:0 PG) Method: X-RAY DIFFRACTION / Resolution: 3.96 Å
IMMUNE SYSTEM / HIV-1 gp41 MPER / 4E10 Fab / lipid membrane / membrane lipid / human anti gp41 HIV-1 4E10 Fab / phosphatidic acid / human 4E10 Fab anti HIV-1 gp41 / membrane lipids / Phosphatidylethanolamine / 4E10 Fab anti HIV-1 gp41 / Phosphatidylcholine / 4E10 Fab anti HIV-1 gp41 MPER / phosphatidylglycerol
+
About Yorodumi Papers
-
News
-
Feb 9, 2022. New format data for meta-information of EMDB entries
New format data for meta-information of EMDB entries
Version 3 of the EMDB header file is now the official format.
The previous official version 1.9 will be removed from the archive.
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator